English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Table of Contents Preface Part I. Sensitization via membrane-bound receptors 1. Sensitization of epithelial cancer cells with human monoclonal antibodies Peter Vollmers and Stephanie Brandlein 2. Targeting the transferrin receptor to overcome resistance to anti-cancer agents Tracy R. Daniels, Isabel I. Neacato, Gustavo Helguera, Manuel L. Penichet 3. Chemo-immunosensitization of resistant B-NHL as a result of rituximab (anti CD20 mAb)-mediated inhibition of cell survival signaling pathways Benjamin Bonavida, Ali R. Jazirehi, Mario I. Vega, Sara Huerta-Yepez, Kazuo Umezawa, and Eriko Suzuki 4. Agents that regulate DR5 and sensitivity to TRAIL Tatsushi Yoshida and Toshiyuki Sakai 5. Proteasome inhibition: Potential for sensitization of immune effector mechanisms in cancer Milad Motarjemi, William H.D. Hallett, Minghui Li, and William J. Murphy Part II. Sensitization via inhibition of cell survival pathways (excluding apoptotic signaling pathways) 6. Angiogenesis inhibitors as chemosensitizing agents for the treatment of metastatic disease Giulio Francia, Urban Emmenegger, and Robert S. Kerbel. 7. Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK and P13K/Akt pathways to sensitize cancer cells to therapy James A. McCubrey, Richard A. Franklin, Fred E. Bertrand, Jackson R. Taylor, illiam H. Chappell, Melissa L. Midgett, Ellis WT. Wong, Stephen L. Abrams, ristin M. Stadelman, Negin Misaghian, Dale E. Lugwid, Jorg Basecke, Massimo ibra, Franca Stivala, Michele Milella, Agostino Tafuri, Alberto M. Martelli, aolo Lungi, Antonio Bonati, David M. Terrian, Brian D. Lehmann, and Linda S. Steelman 8. Histone deacetylase inhibitors and anti-cancer activity Roberto R. Rosato and Steven Grant 9. Eicosanoids and resistance of cancer cells to chemotherapeutic agents Andrey Sorokin Part III. Sensitization via transcription factors 10. The RKIP and STAT3 axis in cancer chemotherapy: opposites attract Devasis Chatterjee, Edmond Sabo, Murray B. Resnick, Kam C. Yeung, and Y. Eugene Chin 11. Targeting transcription factors with decoy oligonucelotides: modulation of the expression of genes involved in chemotherapy resistance of tumor cells Roberto Gambari 12. p53 inhibitors as cancer sensitizing agents Flavio Maina and Rosanna Dono 13. Nitric Oxide-Induced Immunosensitization to Apoptosis by Fas-L and TRAIL Benjamin Bonavida, Sara Huerta-Yepez, Mario I. Vega, Demetrios A. Spandidos and Stravoula Baritaki 14. Natural agents that can sensitize tumor cells to chemotherapy and radiation therapy Ganesh Jagetia, Sunil Krishnan, and Bharat B. Aggarwal Part IV. Sensitization via targeting apoptotic pathways 15. Inhibitors of the Bcl-2 protein family as sensitizers to anticancer agents Daniel E. Johnson 16. Therapeutic targeting of apoptosis in cancer Timothy R. Wilson, Daniel B. Longley, and Patrick G. Johnston 17. Peptides and peptidomimetics as cancer therapy sensitizing agents Shantanu Banerji, Sudharsana Rao Ande, Subbareddy Maddika, Versha Banerji, Iran Rashedi, Neil W. Owens, Anne Zuse, Frank Schweizer, and Marek Los 18. Nonpeptidic mimetics as cancer sensitizing agents Ruud P.M. Dings, Mark Klein, and Kevin H. Mayo 19. Sensitization of cancer cells to cancer therapies by isoflavone and its synthetic derivatives Fazlul H. Sarkar and Yiwei Li 20. Antisense oligonucelotides and siRNA as specific inhibitors of gene expression: mechanisms of action and therapeutic potentitial AS-ODN and siRNA: mechanisms and therapeutic potential Yvonne Forster and Bernd Schwenzer Part V. Sensitization tailored to individual patients 21. DNA

Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy